Patent · US Active

Compounds targeting the cation-independent mannose 6-phosphate receptor

US8962573B2 · kind B2 · utility

6Cited by
2References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 2, 2010
Grant dateFeb 24, 2015
Priority date
Expiry dateAug 3, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to conjugates of products of interest including glycoproteins, nanoparticles, and imaging agents and of compounds of the general formula (1):that target the cation-independent mannose 6-phosphate receptor with a high affinity. The invention also relates to their applications, for instance in enzyme replacement therapies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.